Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Mariana López-Góngora"'
Publikováno v:
Anales de la Facultad de Medicina, Vol 79, Iss 4, Pp 338-345 (2018)
La esclerosis múltiple es una enfermedad inflamatoria, autoinmune y neurodegenerativa del sistema nervioso central caracterizada por pérdida de la función motora y sensitiva; es considerada una de las principales causas de discapacidad en el adult
Externí odkaz:
https://doaj.org/article/9a81466b11aa41c891aab1e1b48293b0
Autor:
Miquel Navas-Madroñal, Ana Valero-Mut, María José Martínez-Zapata, Manuel Javier Simón-Talero, Sebastián Figueroa, Nuria Vidal-Fernández, Mariana López-Góngora, Antonio Escartín, Luis Querol
Publikováno v:
PLoS ONE, Vol 12, Iss 4, p e0175538 (2017)
Antibodies targeting the inward-rectifying potassium channel KIR4.1 have been associated with multiple sclerosis (MS) but studies using diverse techniques have failed to replicate this association. The detection of these antibodies is challenging; KI
Externí odkaz:
https://doaj.org/article/c40202bc53d64b72afb94279120ce78c
Autor:
Mariana López-Góngora, Antonio Escartín, Saul Martínez-Horta, Ramón Fernández-Bobadilla, Luis Querol, Sergio Romero, Miquel Àngel Mañanas, Jordi Riba
Publikováno v:
PLoS ONE, Vol 10, Iss 8, p e0136786 (2015)
Multiple sclerosis (MS) is a chronic central nervous system disorder characterized by white matter inflammation, demyelination and neurodegeneration. Although cognitive dysfunction is a common manifestation, it may go unnoticed in recently-diagnosed
Externí odkaz:
https://doaj.org/article/dbb8d8bf8c644ed7a20418b64c154ffb
Autor:
Antonio Escartin, Marta Miralles, Alejandro Martínez-Domeño, Nuria Vidal, Jordi Espadaler, Mariana López-Góngora
Publikováno v:
Future Neurology. 12:141-148
Aim: Thirty percent of epileptic patients are refractory to treatment. We investigated the association between the number of seizures in refractory epileptic patients and potential interactions between their antiepileptic medications (AEDs) and singl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::874e6622a2bf59a0a4d10bdc2113005d
https://doi.org/10.2217/fnl-2016-0026
https://doi.org/10.2217/fnl-2016-0026
Publikováno v:
Anales de la Facultad de Medicina; Vol 79 No 4 (2018); 338-345
Anales de la Facultad de Medicina; Vol. 79 Núm. 4 (2018); 338-345
Anales de la Facultad de Medicina, Vol 79, Iss 4, Pp 338-345 (2018)
Anales de la Facultad de Medicina, Volume: 79, Issue: 4, Pages: 338-345, Published: OCT 2018
Anales de la Facultad de Medicina; Vol. 79 Núm. 4 (2018); 338-345
Anales de la Facultad de Medicina, Vol 79, Iss 4, Pp 338-345 (2018)
Anales de la Facultad de Medicina, Volume: 79, Issue: 4, Pages: 338-345, Published: OCT 2018
La esclerosis múltiple es una enfermedad inflamatoria, autoinmune y neurodegenerativa del sistema nervioso central caracterizada por pérdida de la función motora y sensitiva; es considerada una de las principales causas de discapacidad en el adult
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a37c9a189fcfa5a42d8fcc2a33dbcae
https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/15641
https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/15641
Autor:
Nuria Vidal-Fernández, Luis Querol, Miquel Navas-Madroñal, Maria José Martinez-Zapata, Ana Valero-Mut, Manuel J. Simón-Talero, Sebastián Figueroa, Antonio Escartin, Mariana López-Góngora
Publikováno v:
PLoS ONE, Vol 12, Iss 4, p e0175538 (2017)
PLoS ONE
PLoS ONE
Introduction Antibodies targeting the inward-rectifying potassium channel KIR4.1 have been associated with multiple sclerosis (MS) but studies using diverse techniques have failed to replicate this association. The detection of these antibodies is ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b2ef505dc03cf7392a515df7a8454f1
http://europepmc.org/articles/PMC5393569?pdf=render
http://europepmc.org/articles/PMC5393569?pdf=render
Publikováno v:
Epileptic disorders : international epilepsy journal with videotape. 10(4)
The purpose of the study was to assess changes in cognitive functions and quality of life in patients with epilepsy over one year of treatment with levetiracetam (LEV) as add-on therapy.Thirty-two patients (16 women; 16 men) who received LEV as an ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ccbf384f2335015a6d1c31654bab7c8f
https://pubmed.ncbi.nlm.nih.gov/19017572
https://pubmed.ncbi.nlm.nih.gov/19017572